Nidderau, Germany

Georg Voelcker

This inventor holds 2 USPTO granted patents. Top assignee: Asta Pharma Aktiengesellschaft. Active years: 1988-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1988-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Georg Voelcker: Innovator in Pharmaceutical Compounds

Introduction

Georg Voelcker is a notable inventor based in Nidderau-Windecken, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, Voelcker's work focuses on innovative solutions for medical treatments.

Latest Patents

Voelcker's latest patents include the development of heterocyclic compounds that exhibit antitumor and AIDS treatment activity. These compounds are characterized by a specific formula that enhances their efficacy in combating these serious health conditions. Additionally, he has patented a method for reducing pain associated with the administration of certain compounds, utilizing a unique combination of chemical structures to improve patient comfort during treatment.

Career Highlights

Throughout his career, Georg Voelcker has been associated with Asta Pharma Aktiengesellschaft, where he has contributed to various research initiatives. His expertise in pharmaceutical chemistry has positioned him as a key player in the development of new therapeutic agents.

Collaborations

Voelcker has collaborated with esteemed colleagues such as Hans-Jurgen Hohorst and Gernot Peter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Georg Voelcker's contributions to pharmaceutical innovations highlight his commitment to improving medical treatments. His patents reflect a dedication to advancing healthcare through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…